Life Sciences and Pharmaceutical

conference webcast

Feb. 9, 2021
7:45 a.m. - 4:00 p.m.

PICPA Member: $345 | Nonmember: $445

Who Should Attend:
CPAs serving small and medium size life sciences, pharma, and biotech companies.

Objective:
To provide insight on accounting best practices, regulatory updates, and financial strategies for CPAs serving small and medium size life science, pharma, and biotech companies.

Can't make the conference on Feb. 9? Catch the replays on Feb. 16 and Feb. 17.

2021 Conference Agenda

7:45 a.m.
 
Greetings from PICPA Leadership
8:00 a.m.
 
1-Other
State of the Industry

 

Molineaux, Christopher
Christopher Molineaux
President & Chief Executive Officer
Life Sciences PA
8:50 a.m.
 
1-Tax
R&D Tax Considerations - Read a preview of this session >
  • COVID-19 legislation and its impact on the economy
  • Employee retention and research credits
  • Net operating loss carryback
Beller, Brandon
Brandon Beller, CPA
Regional Director, Business Development
KBKG
McVoy, Paul
Paul McVoy
Director, Research and Development Tax Credit Services
KBKG

Kniss, Mike
Mike Kniss
Manager, Research and Development Tax Credit Services
KBKG
9:40 a.m.
 
Morning Break
9:55 a.m.
 
2-Other
Funding Strategies and Best Practices
  • Overview of the venture capital landscape
  • IPOs, including their use as an exit or financing event
  • Alternative funding options: equity, grants, and mergers and acquisitions
Geffken, Dan
Daniel Geffken
Managing Director
Danforth Advisors LLC
cpamember
Barb Carlin
Managing Director, Mid-Atlantic Region
Danforth Advisors

Gross, Ricky
Ricky Gross
Senior Manager – Audit and Assurance
Deloitte
cpamember
Mark Hanulak
Senior Manager
Deloitte

Gillespie, Derek
Derek Gillespie
Partner
Deloitte
11:35 a.m.
 
Lunch Break
12:25 p.m.
 
1-A&A
Regulatory Updates
  • Summary of AICPA conference on current SEC and PCAOB developments
  • Latest updates on current standard-setting and rule-making from the FASB
  • Implementation issues 
  • Post year-end reminders
cpamember
Doug Lauckhardt
Managing Director
Grant Thornton LLP
Taylor, Andrew
Andrew Taylor
Director
Grant Thornton LLP
1:15 p.m.
 
1-A&A
Revenue Accounting within the Pharmaceutical and Life Sciences Industry
  • Gross to Net (GTN) foundational concepts
  • Role of data analytics
  • Focus on profitability
Lubold, Nick
Nick Lubold, CPA
Manager, Audit and Assurance
Deloitte
2:05 p.m.
 
Afternoon Break
2:20 p.m.
 
1-Other
Collaborative Arrangements
  • Costs and risks of collaborating with third parties
  • What activities make up collaborative arrangements?
  • How arrangements vary in scope, terms, and conditions
  • Risk mitigation considerations
Miles, Morgan
Morgan Miles, CPA
Senior Manager, Accounting and Reporting Advisory
Deloitte
3:10 p.m.
 
1-A&A
Capitalization and Impairment
  • Internal development costs related to timing and regulatory approval
  • Development costs and expenditures
  • Indicators of impairment, including intangibles, property, plant, and equipment
  • Impairment testing and useful life
Hudson, Chris
Chris Hudson
Assurance Partner
PwC
Raymond, Alex
Alex Raymond
Assurance Director
PwC
4:00 p.m.
 
See You Next Year

Credits

CPE Credits: 3-A&A; 1-Tax; 4-Other

Level: Update
Prerequisites: None

CLE Credits: This conference has been submitted for 6.5 Substantive CLE credits. Attorneys requesting CLE credits must include an additional $50.

Registration

PICPA Member: $345
Nonmember: $445
CLE Credits Fee: $50

ClassPass      flexAccount200x75

Use your ClassPass, ClassPass Mini, or Flex Account to register. Find more information about PICPA discounts.

Sign Up for Conference Announcements